The Mechanistic Biology of Primary Immunodeficiency Disorders | MicrobiomeTrials← Back to trialsNCT03394053
The Mechanistic Biology of Primary Immunodeficiency Disorders
RecruitingOBSERVATIONAL
Trial Details
Start: 2018-05-30Est. Completion: 2029-12-31
Enrollment target: 2,500 participants Locations- Children's National Health System (CNHS), Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
HivOpioid Use Disorder
The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorde…
New Haven, United StatesEst. completion Jan 2027
EczemaAtopic Dermatitis
This study will examine microbes (e.g., bacteria, fungi, viruses) that live on human skin and how microbes contribute to…
Bethesda, United States
Phase 3
Recruiting
Secondary Immune Deficiency
This is a prospective, multicenter, open-label, single-arm study to assess the efficacy, safety, and pharmacokinetics (P…
Multiple LocationsEst. completion Feb 16, 2029